Cannabidiol Research Performed in Collaboration with Lewis Katz School of Medicine to be Presented at International Symposium

Kannalife, Inc., a biopharmaceutical company focused on the research, development and discovery of cannabinoid therapeutic agents, will present the company’s recent research findings at the 29th Annual International Cannabinoid Research Society Symposium on the Cannabinoids in Bethesda, Maryland, on July 2. This research was done in collaboration with the Lewis Katz School of Medicine at Temple University (LKSOM) and was recently published in the Journal of Molecular Neuroscience. Sara Jane Ward, PhD, Assistant Professor of Pharmacology at LKSOM, began research on cannabidiol prior to the Kannalife agreement. Markets Insider, Morningstar, the Arizona Republic, and other outlets covered the news.